A Personalized Therapeutics Approach Using an In Silico

MN Gondal, RN Butt, OS Shah, MU Sultan… - … for Cancer Treatment …, 2022 - books.google.com
Gondal MN, Butt RN, Shah OS, Sultan MU, Mustafa G, Nasir Z, Hussain R, Khawar H, Qazi
R, Tariq M, Faisal A and Chaudhary SU (2021) A Personalized Therapeutics Approach …

In silico Drosophila Patient Model Reveals Optimal Combinatorial Therapies for Colorectal Cancer

MN Gondal, RN Butt, OS Shah, Z Nasir, R Hussain… - bioRxiv, 2020 - biorxiv.org
In silico models of biomolecular regulation in cancer, annotated with patient-specific gene
expression data can aid in the development of novel personalized cancer therapeutics …

A Personalized Therapeutics Approach Using an In Silico Drosophila Patient Model Reveals Optimal Chemo- and Targeted Therapy Combinations for Colorectal …

MN Gondal, RN Butt, OS Shah, MU Sultan… - Frontiers in …, 2021 - frontiersin.org
In silico models of biomolecular regulation in cancer, annotated with patient-specific gene
expression data, can aid in the development of novel personalized cancer therapeutic …

[引用][C] Personalized Medicine: Harnessing an Artificial Intelligence Platform to Dynamically Individualize Combination Therapy for Treating Colorectal Carcinoma in a …

X Ding, VHS Chang, Y Li, X Li, H Xu… - Advanced …, 2020 - Wiley Online Library
In article number 1900127, Chih-Ming Ho, Dean Ho, Yun Yen and co-workers harness an
artificial intelligence platform that is mechanism free and can dynamically optimize …

Harnessing an artificial intelligence platform to dynamically individualize combination therapy for treating colorectal carcinoma in a rat model

X Ding, VHS Chang, Y Li, X Li, H Xu… - Advanced …, 2020 - Wiley Online Library
Designing multi‐drug regimens often involves target‐and synergy prediction‐based drug
selection, and subsequent dose escalation to achieve the maximum tolerated dose (MTD) of …

Abstract PR03: Identifying biomarkers of drug response and resistance using personalized Drosophila models of colorectal cancer

E Bangi, C Murgia, A Teague, O Sansom… - Clinical Cancer Research, 2015 - AACR
A fundamental difficulty in cancer research is the complex, multigenic and genetically
diverse nature of human tumors, recently emphasized by cancer genome sequencing …

Abstract B002: Modeling evolutionary therapy for GI malignancies

GLR Arul, E Tolosa, RM Carr, ME Fernandez-Zapico - Cancer Research, 2022 - AACR
Despite development of personalized treatments GI cancer like pancreatic ductal
adenocarcinoma (PDAC) and colorectal cancer (CRC) remain dismal outcomes. While …

Galaxy and MEAN Stack to create a user-friendly workflow for the rational optimization of cancer chemotherapy

JG Pires, GF Da Silva, T Weyssow, AJ Conforte… - Frontiers in …, 2021 - frontiersin.org
One aspect of personalized medicine is aiming at identifying specific targets for therapy
considering the gene expression profile of each patient individually. The real-world …

Mathematical modeling and systems biology applications in oncology

CS Harkos - 2024 - gnosis.library.ucy.ac.cy
This thesis uses the valuable tool of mathematical modelling to model and analyse complex
biological systems (Systems Biology) to investigate tumor progression and treatment. It …

[PDF][PDF] Can computers conceive the complexity of cancer to cure it? Using artificial intelligence technology in cancer modelling and drug discovery

RC Adams, B Rashidieh - Mathematical Biosciences and …, 2020 - researchgate.net
Drug discovery and the development of safe and effective therapeutics is an intricate
procedure, further complicated in the context of cancer research by the inherent …